Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

Figure 6

Effect of DSS1 knockdown on the drug sensitivity of MCF7 and MDA-MB-231 cells. Drug sensitivity was examined in DSS1 knockdown cells with an optimized dose of CPT (50 μM) and ETP (50 μM). MCF7 and MDA-MB-231 cells were first treated with siDSS1 for 2 days and then cultured with CPT (A) or ETP (B) for 2 days. (A) and (B) The number of cells in the sub-G1 (dead) cell populations was compared between siDSS1-(a)- or siCtrl-treated cells. The results of cell cycle profiling (left) were converted into the graph, which represents more than three independent experiments (right). Statistical significance was assessed by Student’s t-test, with **P < 0.01 and ***P < 0.001.

Back to article page